Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People
July 21, 2014
TheStreet / Powered by NewsLook.com
New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York.
Video provided by TheStreet
AFP (Apr. 8, 2013) South Africa's health minister launches a new single dose anti-AIDS drug, which reduces the need for HIV positive patients to take multiple pills each day. The country has the largest HIV positive ... watch video
NDTV (May 7, 2013) It is not a girl's world, at least not in India where there are only 919 girls under six for every 1000 boys. The 2011 census figures show the ratio has fallen further from the already alarming 927 ... watch video
Newsy (July 10, 2014) The anonymous infant's "functional cure" last year raised hopes of a treatment for HIV-positive babies, but the virus finally re-emerged in the girl.
Video provided by ... watch video
FORA.tv (May 9, 2013) Dr Joep Lange has been involved in HIV research and treatment since 1983. He has been the architect and principal investigator of several pivotal trials on antiretroviral therapy and on the ... watch video
Newsy (July 22, 2015) Eli Lilly is debuting solanezumab, its new drug designed to cure Alzheimer's. But will the drug fare better than past trials have foreshadowed?
Video provided by ... watch video
Nov. 24, 2015 Fat cells produced by stem cells from the bone marrow may be linked to chronic illnesses like diabetes, cardiovascular disease, kidney disease and some cancers, researchers ... read more
Nov. 24, 2015 Older people with visual impairment can report feeling dizzy and falling. A new study found that after routine cataract surgery, the improved vision led to patients experiencing significantly less ... read more
Nov. 24, 2015 A group of people with fatal H1N1 flu died after their viral infections triggered a deadly hyperinflammatory disorder in susceptible individuals with gene mutations linked to the overactive immune ... read more
Nov. 24, 2015 An exciting advance provides hope for developing novel potential method of treating pneumococcal diseases such as bacterial pneumonia, meningitis and septicaemia. A team of ... read more
Nov. 24, 2015 Anxiety around the arrival of a new baby is just as common as postnatal depression, and the risks for men are nearly as high as for women, researchers have found. A mental health researcher reviewed ... read more
Nov. 23, 2015 A significant reduction in diabetes-related amputations since the mid-1990s has been identified by a new study. Researchers credit this decline to improvements in diabetes care over this ... read more
Mar. 31, 2015 HIV (human immunodeficiency virus)-positive kidney transplant patients experienced superior outcomes when compared to kidney transplant patients with Hepatitis C and those infected with both HIV and ... read more
July 23, 2014 Treatment of HIV patients co-infected with the hepatitis C virus (HCV) with an anti-retroviral drug therapy not only tackles HIV, but also reduces HCV replication, according to a new ... read more
Jan. 15, 2014 Efforts to cure hepatitis C, the liver-damaging infectious disease that has for years killed more Americans than HIV/AIDS, are about to get simpler and more effective, according to new ... read more
Feb. 1, 2011 Researchers examined the role of later acquisition of hepatitis C in HIV patients in a new study. The findings suggest HIV patients should have access to ongoing screening for hepatitis ... read more